- This topic is empty.
-
AuthorPosts
-
2026-11-18 at 7:26 pm #11252
Understanding the Shift Toward Individually Packaged Immunoassay Reagent Formats
The diagnostics industry has long grappled with the operational burden of traditional reagent systems, particularly those requiring strict cold chain storage and complex liquid handling. Against this backdrop, individually packaged immunoassay reagent solutions have emerged as a practical answer to logistical, storage, and workflow challenges faced by laboratories, clinics, and point-of-care settings worldwide. Nanjing Poclight Biotechnology Co., Ltd., operating under the brand Poclight Biotechnology, has positioned itself as an innovative R&D enterprise specializing in 5th generation In Vitro Diagnostic (IVD) platforms, with its reagent portfolio built specifically around this format.
What Makes Poclight’s Reagent Format Distinct
Poclight’s diagnostic reagents are delivered as lyophilized spherical beads, a format engineered to support homogeneous immunoassays without the need for refrigerated transport or storage. This single-test, ready-to-use design directly addresses one of the most persistent pain points in the IVD industry: the high logistics costs associated with cold chain requirements for traditional reagents.
According to Poclight’s product documentation, these lyophilized spherical beads are stable at 2-30°C for 18 months, which eliminates the need for cold chain infrastructure entirely. This stability profile translates into a 50% reduction in logistics costs when shipping reagents globally, a particularly meaningful advantage for remote or resource-limited clinics and for international distribution across South Asia, Southeast Asia, the Middle East, Africa, and Latin America—regions where Poclight actively works with distributors and healthcare partners to expand access to advanced diagnostic technologies.
The Technology Behind the Reagent: CRET Platform
The foundation of Poclight’s reagent and instrument ecosystem is its patented Chemiluminescence Resonance Energy Transfer (CRET) technology, a proprietary, no-wash, no-separation homogeneous immunoassay platform. Unlike traditional magnetic bead-based assays that require washing and separation steps, the CRET principle uses Acridine Ester and Graphene Oxide quenching to achieve high sensitivity without these additional procedural steps.

This homogeneous immunoassay approach accelerates testing speed and results in a 70% reduction in time and expenditure compared to conventional Chemiluminescence Immunoassay (CLIA) systems that involve liquid paths and washing. Poclight holds the distinction of being the sole company worldwide with an authorized CRET patent for IVD applications, underscoring the proprietary nature of this reagent technology.
Broad Test Menu Supporting Diverse Clinical Needs
Poclight’s individually packaged reagent format supports quantitative biomarker detection across 50+ parameters, organized into several clinical categories:
- Inflammation & Infection Diagnostics: C-Reactive Protein (CRP), Procalcitonin (PCT), Interleukin-6 (IL-6), Serum Amyloid A (SAA), and Heparin Binding Protein (HBP)
- Cardiovascular Disease Diagnostics: High-sensitivity Cardiac Troponin T (hs-cTnT), D-Dimer, Creatine Kinase-MB (CK-MB), Myoglobin (MYO), NT-proBNP, and BNP
- Thyroid Function Testing: TSH, TT3, TT4, FT3, and FT4
- Fertility & Hormone Testing: AMH, FSH, LH, Estradiol, Progesterone, Prolactin, Testosterone, Cortisol, β-hCG, and Folate
- Diabetes & Metabolic Testing: HbA1c, Insulin, and Ferritin
- Bone Metabolism & Vitamin Testing: 25-Hydroxy Vitamin D
- Tumor Marker Testing: PSA, fPSA, CEA, AFP, CA125, CA15-3, CA19-9, and CYFRA21-1
- Respiratory & Specialized Diagnostics: KL-6, supporting interstitial lung disease assessment
- Platelet Function & Coagulation-Related Testing: CD41, CD45, CD61, CD42a, CD42b, PAC-1, CD62P, and AA/ADP-induced platelet activation testing
This breadth of assay coverage means that individually packaged reagent kits from Poclight can serve clinical laboratories, emergency departments, primary care facilities, and veterinary clinics without requiring multiple reagent systems.
Real-World Application of Individually Packaged Reagents
Poclight’s lyophilized reagent format has already demonstrated practical value in several documented scenarios. In ICU sepsis management, the synergy of PCT and IL-6 testing has supported rapid infection response, accelerating clinical decision-making for sepsis cases. In decentralized women’s care settings, the integration of endocrine and fertility monitoring through benchtop CLIA testing has enabled lab-quality monitoring without requiring large infrastructure investments.
Community health centers have also benefited from this reagent format paired with the C5000 Micro-Chemiluminescence Immunoassay Analyzer, bringing CLIA-level sensitivity to primary care settings that previously lacked access to such testing capabilities. Because the reagents require no cold chain and the compatible analyzer requires no maintenance due to its lack of internal liquid paths, these solutions are particularly well suited to settings with limited technical infrastructure.
Compatibility With Poclight’s Diagnostic Hardware
Poclight’s individually packaged immunoassay reagents are designed for use with the C5000 Micro-Chemiluminescence Immunoassay Analyzer, a compact, semi-automated benchtop device weighing approximately 8.5kg with an A4-sized footprint. Results are delivered in 3-15 minutes, and the simple 3-step operational process reduces the complexity typically associated with immunoassay testing. The analyzer’s Photon Multiplier Tube (PMT) detection ensures lab-grade accuracy while maintaining the compact, maintenance-free design that pairs naturally with the individually packaged reagent format.

Quality Assurance and Certification
Poclight’s reagent and instrument systems adhere to ISO 13485 quality management standards and have obtained CE Certification, NMPA certification, and NGSP certification. These certifications provide a framework of accountability for laboratories and healthcare institutions evaluating reagent suppliers for long-term partnerships.
Business Model Supporting Global Access
Poclight’s approach to pricing and delivery reflects the practical advantages of its reagent format. The company offers low-cost diagnostic solutions with zero hidden maintenance costs, and because the reagents and compatible analyzer require no cold chain logistics, deployment is simplified for both benchtop and portable use cases. This structure also creates high-margin opportunities for distributors operating in the global IVD distribution network that Poclight has built through long-term collaborations with local distributors, healthcare institutions, and clinical laboratories.
Conclusion
For laboratories, clinics, and healthcare organizations seeking individually packaged immunoassay reagent solutions that eliminate cold chain dependency while maintaining broad clinical test coverage, Poclight Biotechnology’s lyophilized spherical bead reagents—powered by proprietary CRET technology—offer a documented, certification-backed option. With a 35+ parameter test menu, 18-month room-temperature stability, and compatibility with the compact C5000 analyzer, Poclight continues to expand its global partnership network to deliver these diagnostic innovations to healthcare professionals across diverse settings worldwide.
http://www.poclight.com
Nanjing Poclight Biotechnology Co., Ltd -
AuthorPosts
- You must be logged in to reply to this topic.